Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07676266 A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory … |
C-CAR168 | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | RenJi Hospital | China · The Affiliated Hospital of Qingdao University… | 2026-07 → 2028-10 | Ouvrir |
| NCT04544449 FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib… |
Fenebrutinib | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Austria, Brazil,… | 2020-10-26 → 2027-07-21 | Ouvrir |
| NCT07341828 A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmu… |
C-CAR168 | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | RenJi Hospital | Non communiqué | 2026-02 → 2029-02 | Ouvrir |
| NCT06249438 CAR-AID — A Study of C-CAR168 in the Treatment of Autoimmune Diseases R… |
C-CAR168 | SEP | Phase 1 | RECRUITING | En attente / non publié | RenJi Hospital | China · Department of Rheumatology, RenJi Hospital, S… | 2024-03-20 → 2040-03 | Ouvrir |
| NCT06595706 Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses … |
Lucid-MS (Lucid-21-302) | SEP | Phase 1 | COMPLETED | En attente / non publié | Huge Biopharma Australia Pty Ltd | Australia · Cmax Clinical Research, Adelaide, Austral… | 2024-09-28 → 2025-01-24 | Ouvrir |
| NCT05821387 Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Fo… |
Lucid-MS (Lucid-21-302) | SEP | Phase 1 | COMPLETED | En attente / non publié | Huge Biopharma Australia Pty Ltd | Canada · Biopharma Services Incorporated, Toronto, Ca… | 2023-03-22 → 2023-07-29 | Ouvrir |
| NCT01702025 Rapid Acclimatization to Hypoxia at Altitude |
Aminophylline | SEP | Phase 1/2 | COMPLETED | En attente / non publié | Thies Schroeder | United States · Colorado State University, Dept. of H… | 2012-06 → 2012-12 | Ouvrir |
| NCT01412827 SPECT-Light — Accuracy of Half of the Usual Radiotracer Dose in SPECT |
1/2 dose of 99mTc OR 201Tl tracers | SEP | Non applicable | COMPLETED | En attente / non publié | Ottawa Heart Institute Research C… | Canada · University of Ottawa Heart Institute, Ottawa… | 2010-04 → 2014-09 | Ouvrir |
| NCT05666219 Reversal of Complete Heart Block With Aminophylline in Inferior Wall My… |
Aminophylline Injection | SEP | Phase 4 | WITHDRAWN | En attente / non publié | National Institute of Cardiovascu… | Non communiqué | 2022-12-19 → 2025-01-17 | Ouvrir |
| NCT01655524 ASSUAGE-MPI — The Impact of the Routine Aminophylline Administration Fo… |
ASSUAGE Protocol | SEP | Phase 4 | WITHDRAWN | En attente / non publié | Rush University Medical Center | United States · Rush University Medical Center, Chica… | 2012-07 → 2014-07 | Ouvrir |
| NCT02983422 Effects of Aminophylline on Renal Function and Urine Volume of AKI Pati… |
Aminophylline | SEP | Phase 1 | UNKNOWN | En attente / non publié | Thies Schroeder | Non communiqué | 2016-12 → 2017-07 | Ouvrir |
| NCT04240821 Theophylline for Treatment of Pseudohypoparathyroidism |
Theophylline ER | SEP | Phase 2 | ENROLLING_BY_INVITATION | En attente / non publié | Jaclyn Tamaroff | United States · Vanderbilt University Medical Center,… | 2020-05-22 → 2026-12-31 | Ouvrir |
| NCT01509248 Population Pharmacokinetics and Metabolomics of Theophylline in Preterm… |
Population Pharmacokinetics and M… | SEP | À vérifier | UNKNOWN | En attente / non publié | Seoul National University Hospital | Non communiqué | 2010-05 | Ouvrir |
| NCT03718403 Effect of Theophylline in Pseudohypoparathyroidism |
Theophylline | SEP | Phase 4 | RECRUITING | En attente / non publié | Massachusetts General Hospital | United States · Massachusetts General Hospital, Bosto… | 2019-11-11 → 2032-04-10 | Ouvrir |
| NCT01684683 The Effect of Theophylline in the Treatment of Bronchiectasis |
Theophylline | SEP | Phase 4 | COMPLETED | En attente / non publié | Massachusetts General Hospital | China · State Key Laboratory of Respiratory Research … | 2012-11 → 2014-09 | Ouvrir |
| NCT01263106 A Study of LY2216684 and Theophylline in Healthy Subjects |
LY2216684 | SEP | Phase 1 | COMPLETED | En attente / non publié | Eli Lilly and Company | United States · For additional information regarding … | 2010-12 → 2011-01 | Ouvrir |
| NCT07818772 7T Imaging Pilot-study in Patients With Motor Neuron Disease to Find No… |
MRI | Sclérose latérale amyotrophique | À vérifier | RECRUITING | En attente / non publié | National Institute of Neurologica… | United Kingdom · ICE Building, Glasgow, United Kingdom | 2026-04-13 → 2026-11-30 | Ouvrir |
| NCT06363357 The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Func… |
Shoulder orthosis | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | Seoul National University Hospital | South Korea · Seoul National University Hospital, Seo… | 2024-04-20 → 2025-12-31 | Ouvrir |
| NCT07521930 Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) |
INTENT Neural Interface System | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins Medicine, Baltimore, Un… | 2026-09 → 2028-12 | Ouvrir |
| NCT07818291 An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adult… |
EA5 | Myasthénie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Shanghai Lanyi Therapeutics Co., … | China · Beijing Hospital, Beijing, China | Huashan Ho… | 2026-09-15 → 2027-12-31 | Ouvrir |
| NCT06392386 ADAPT Jr SC — A Study of Efgartigimod PH20 SC in Children Between 2 and… |
Efgartigimod PH20 SC | Myasthénie | Phase 2/3 | RECRUITING | En attente / non publié | argenx | United States, Australia, Belgium, Canada, Czechia, F… | 2024-06-28 → 2027-09 | Ouvrir |
| NCT05403541 Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induct… |
Batoclimab 680 mg SC weekly | Myasthénie | Phase 3 | TERMINATED | En attente / non publié | Immunovant Sciences GmbH | United States, Argentina, Brazil, Canada, Georgia, Ge… | 2022-06-27 → 2026-08-07 | Ouvrir |
| NCT05150210 SP Thoracic IDE Study |
Robotic-Assisted Surgery | Myasthénie | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Intuitive Surgical | United States · Brigham and Women's Hospital, Boston,… | 2022-07-20 → 2028-07 | Ouvrir |
| NCT07503821 SYVIPRO — Synovial Tissue as a Biomarker in the Management of Pigmented… |
synovial biopsy | Myopathies | Non applicable | RECRUITING | En attente / non publié | Nantes University Hospital | France · CHU de Nantes, Nantes, France | Hôpital Coch… | 2026-09 → 2030-09 | Ouvrir |
| NCT07736144 Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyal… |
Yangyin Roujin Decoction | Myopathies | Non applicable | RECRUITING | En attente / non publié | Juan Jiao | China · Guang'anmen Hospital of China Academy of Chin… | 2025-01-01 → 2027-12-30 | Ouvrir |